Table 1.
Control group | Observation group | ||||
---|---|---|---|---|---|
|
|
||||
Indicators | Before treatment | After treatment | Before treatment | After treatment | |
Fat percent (%) | 32.58±2.36 | 29.44±2.25a | 32.71±2.34 | 27.44±2.28b,c | |
TC (mmol/L) | 5.64±0.31 | 5.11±0.29a | 5.76±0.33 | 4.25±0.32b,c | |
TG (mmol/L) | 2.12±0.22 | 1.91±0.21a | 2.14±0.24 | 1.59±0.22b,c | |
LDL-C (mmol/L) | 3.15±0.30 | 2.87±0.28a | 3.16±0.26 | 2.40±0.25b,c | |
HDL-C (mmol/L) | 1.12±0.13 | 1.30±0.16a | 1.11±0.12 | 1.51±0.19b,c | |
Whole blood high shear viscosity (mpa.s) | 5.34±0.53 | 5.07±0.48a | 5.36±0.59 | 4.52±0.56b,c | |
Whole blood low shear viscosity (mpa.s) | 8.63±0.92 | 8.14±0.86a | 8.64±1.01 | 7.72±0.94b,c | |
Plasma viscosity (mpa.s) | 1.91±0.12 | 1.83±0.11a | 1.93±0.14 | 1.65±0.13b,c | |
Erythrocyte sedimentation indicator (mm/L) | 16.36±5.71 | 15.92±5.45a | 16.52±6.11 | 13.73±5.43b,c |
Note: comparison of the control group before and after treatment;
P<0.05.
Comparison of the observation group before and after treatment;
P<0.05.
Comparison of the control group and the observation group after treatment;
P<0.05.